According to the announcement, Shenzhen Huada Gene Technology Co., Ltd., the controlling shareholder of the company, released the pledge of 7.6 million shares on August 18, 2026, accounting for 1.82% of the company's total share capital; on the same day, another 6.9 million shares were pledged, accounting for 1.65% of the company's total share capital. The use of the pledge was for its own production and operation capital requirements, and each pledge was the Shenzhen branch of China Merchants Bank. As of the disclosure date of the announcement, the controlling shareholders and their co-actors pledged a total of 90.73 million shares, accounting for 69.25% of their shares and 21.69% of the company's total share capital. The risk of the pledge is manageable and will not lead to a change in the actual control of the company.

According to the announcement, Shenzhen Huada Gene Technology Co., Ltd., the controlling shareholder of the company, released the pledge of 7.6 million shares on August 18, 2026, accounting for 1.82% of the company's total share capital; on the same day, another 6.9 million shares were pledged, accounting for 1.65% of the company's total share capital. The use of the pledge was for its own production and operation capital requirements, and each pledge was the Shenzhen branch of China Merchants Bank. As of the disclosure date of the announcement, the controlling shareholders and their co-actors pledged a total of 90.73 million shares, accounting for 69.25% of their shares and 21.69% of the company's total share capital. The risk of the pledge is manageable and will not lead to a change in the actual control of the company.